The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
Abstract
What's known on the subject? and What does the study add? Endoscopic management of upper tract urothelial carcinoma (UTUC) using either ureteroscopy and laser ablation, or percutaneous resection, is a management option for treating selected low‐grade tumours with favourable characteristics. However, the evidence base for such practice is relatively weak, as the reported experience is mainly limited to small case series (level of evidence 4), or non‐randomised comparative studies that are unmatched for tumour stage (level of evidence 3b), with variability of follow‐up duration and reported outcome measures. The present systematic review comprehensively reviews the outcomes of all studies of endoscopic management of UTUC, including the role of topical adjuvant therapy. It establishes for the first time a structured reference for endoscopic management of UTUC, and is a foundation for further clinical studies. OBJECTIVE: To systematically review the oncological outcomes of upper tract urothelial carcinoma (UTUC) treated with ureteroscopic and percutaneous management. The standard treatment of UTUC is radical nephroureterectomy (RNU). However, over the last two decades several institutions have treated UTUC endoscopically, either via ureteroscopic ablation or percutaneous nephroscopic resection of tumour (PNRT), for both imperative and elective indications. METHODS: For evidence acquisition the Pubmed database was searched for English language publications in December 2011 using the following terms: upper tract (UT) transitional cell carcinoma (TCC), upper tract TCC, UTTCC, upper tract urothelial cell carcinoma, upper tract urothelial carcinoma, UTUC, endoscopic management, ureteroscopic management, laser ablation, percutaneous management, PNRT, conservative management, ureteroscopic biopsy, biopsy, BCG, mitomycin C, topical therapy. RESULTS: There are no randomised trials comparing endoscopic management with RNU. Most published studies were retrospective case series (and database reviews), or unmatched comparative studies. There was strong selection bias for favourable tumour characteristics in many endoscopically treated groups. There was variation in medical comorbidity and indication for treatment across different study groups. The biopsy verification of underlying UTUC pathology was inconsistent. The follow‐up in most studies was limited, typically to a mean 3 years. CONCLUSIONS: There is a high rate of UT recurrence with endoscopically managed UTUC, and a grade‐related risk of tumour progression and disease‐specific mortality. Overall, renal preservation may be high with ≈20% of patients proceeding eventually to RNU. For highly selected Grade 1 (or low‐grade) disease managed in experienced centres, 5‐year disease‐specific survival (DSS) may be equivalent to RNU, although the small study groups and short follow‐ups preclude comments on less favourable Grade 1 (or low‐grade) tumour characteristics, or DSS, in the longer‐term. For Grade 3 (or high‐grade) disease, DSS outcomes are poor and endoscopic management should only be considered for compelling imperative indications in the context of the patient's overall life expectancy and competing comorbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Cited by
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Rouprêt, M., Babjuk, M., Compérat, E., Zigeuner, R., Sylvester, R. J., Burger, M., Cowan, N. C., Gontero, P., Van Rhijn, B. W. G., Mostafid, A. H., et al. (2018) · European Urology · doi:10.1016/j.eururo.2017.07.036 · Cited by 1,514
Rouprêt, M., Babjuk, M., Compérat, E., Zigeuner, R., Sylvester, R. J., Burger, M., Cowan, N. C., Böhle, A., Van Rhijn, B. W. G., Kaasinen, E., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.06.044 · Cited by 1,341
European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
Rouprêt, M., Babjuk, M., Compérat, E., Zigeuner, R., Sylvester, R., Burger, M., Cowan, N., Böhle, A., Van Rhijn, B. W. G., Kaasinen, E., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.03.032 · Cited by 451
Seisen, T., Peyronnet, B., Dominguez-Escrig, J. L., Bruins, H. M., Yuan, C. Y., Babjuk, M., Böhle, A., Burger, M., Compérat, E. M., Cowan, N. C., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.07.014 · Cited by 323
Metadata
- Authors
- Cutress, M. L., Stewart, G. D., Zakikhani, P., Phipps, S., Thomas, B. G., & Tolley, D. A.
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2012-04-03
- Volume
- 110
- Issue
- 5
- Pages
- 614-628
- ISSN
- 1464-4096 (ISSN-L)
- 1464-410X
- OpenAlex
- W2165027975
- Cited by
- 252
- References
- 1
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. https://app.cochat.ai/papers/10.1111/j.1464-410x.2012.11068.x
- The paper
- Cutress, M. L., Stewart, G. D., Zakikhani, P., Phipps, S., Thomas, B. G., & Tolley, D. A. (2012). Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU International. https://doi.org/10.1111/j.1464-410x.2012.11068.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.